{"product_id":"ucsf-42nd-annual-advances-in-heart-disease-2025","title":"UCSF 42nd Annual Advances in Heart Disease 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOur 42nd annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence.\u003c\/p\u003e\n\u003cp\u003eOur faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.\u003c\/p\u003e\n\u003cp\u003eTARGET AUDIENCE\u003c\/p\u003e\n\u003cp\u003eThis course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eAn attendee completing this course will be able to improve skills and strategies to:\u003c\/h3\u003e\n\u003cp\u003eProvide the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation, STEMI and non-STEMI, thromboembolic disease;\u003c\/p\u003e\n\u003cp\u003eRefine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation;\u003c\/p\u003e\n\u003cp\u003eApply the best considerations of percutaneous interventions for coronary heart disease;\u003c\/p\u003e\n\u003cp\u003eImprove the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases;\u003c\/p\u003e\n\u003cp\u003eRecognize risk stratification of cardiovascular disease;\u003c\/p\u003e\n\u003cp\u003eApply the best consideration of percutaneous treatment of valvular heart disease;\u003c\/p\u003e\n\u003cp\u003eRecognize that pathophysiology of diseases and treatment options are impacted by social determinants of health and implement strategies to improve health outcomes among all patients.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDate\/Time\u003c\/p\u003e\n\u003cp\u003eTopic\/Title\u003c\/p\u003e\n\u003cp\u003eSpeaker(s)\u003c\/p\u003e\n\u003cp\u003eFriday,\u003c\/p\u003e\n\u003cp\u003eDec 12, 2025\u003c\/p\u003e\n\u003cp\u003e7:50 AM\u003c\/p\u003e\n\u003cp\u003eCourse Webinar Opens\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eWelcome and Symposium Overview\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD, FACC\u003c\/p\u003e\n\u003cp\u003eSession: Frontiers in Interventional Cardiology\u003c\/p\u003e\n\u003cp\u003eChair: Lucas Zier, MD, MS\u003c\/p\u003e\n\u003cp\u003e8:05\u003c\/p\u003e\n\u003cp\u003eProactive Management of Severe Aortic Stenosis: From Detection to Early Treatment\u003c\/p\u003e\n\u003cp\u003eSammy Elmariah, MD, MPH, FACC\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eUpdates on the Management of Mitral and Tricuspid Valve Disease\u003c\/p\u003e\n\u003cp\u003eMichela Faggioni, MD, FACC\u003c\/p\u003e\n\u003cp\u003e9:25\u003c\/p\u003e\n\u003cp\u003eA New Perspective on Old Therapies for Myocardial Infarction: Beta Blockers and Spironolactone\u003c\/p\u003e\n\u003cp\u003eKrishan Soni, MD, MBA, FACC\u003c\/p\u003e\n\u003cp\u003e10:05\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e10:20\u003c\/p\u003e\n\u003cp\u003eJohn MacGregor, MD, PhD, FACC\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003eRenal Denervation Therapy for Resistant Hypertension\u003c\/p\u003e\n\u003cp\u003eJoseph Yang, MD, FACC\u003c\/p\u003e\n\u003cp\u003e11:40\u003c\/p\u003e\n\u003cp\u003eUpdates on Chronic Total Occlusions and Complete Revascularization\u003c\/p\u003e\n\u003cp\u003eYousif Ahmad, MBBS, PhD\u003c\/p\u003e\n\u003cp\u003e12:20 PM\u003c\/p\u003e\n\u003cp\u003eLunch (Optional Product Theater)\u003c\/p\u003e\n\u003cp\u003eSession: Advances in Cardiovascular Disease Management and Prevention\u003c\/p\u003e\n\u003cp\u003eChair: Peter Ganz, MD\u003c\/p\u003e\n\u003cp\u003e1:50 PM\u003c\/p\u003e\n\u003cp\u003eCardiovascular-kidney-metabolic (CKM) Syndrome\u003c\/p\u003e\n\u003cp\u003eChiadi E. Ndumele, MD, PhD\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eElliot Rapaport, MD Keynote Lecture: Pulmonary Embolism- Historical Perspective and Glimpses into the Future\u003c\/p\u003e\n\u003cp\u003eSamuel Z. Goldhaber, MD\u003c\/p\u003e\n\u003cp\u003e3:15\u003c\/p\u003e\n\u003cp\u003eUpdate on the Management of Hypertension – 2025 AHA\/ACC Guidelines\u003c\/p\u003e\n\u003cp\u003eMary Gray, MD\u003c\/p\u003e\n\u003cp\u003e3:55\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e4:10\u003c\/p\u003e\n\u003cp\u003eUpdate on Cardiovascular Complications of Cancer Treatments\u003c\/p\u003e\n\u003cp\u003eJavid Moslehi, MD\u003c\/p\u003e\n\u003cp\u003e4:50\u003c\/p\u003e\n\u003cp\u003eContemporary Pulmonary Hypertension Management\u003c\/p\u003e\n\u003cp\u003eMarc Simon, MD, MS, FACC\u003c\/p\u003e\n\u003cp\u003e5:30\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eSaturday,\u003c\/p\u003e\n\u003cp\u003eDec 13, 2025\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e7:50\u003c\/p\u003e\n\u003cp\u003eCourse Webinar Opens\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD\u003c\/p\u003e\n\u003cp\u003eSession: Advances and Controversies in Electrophysiology\u003c\/p\u003e\n\u003cp\u003eChair: Nora Goldschlager, MD, FACC\u003c\/p\u003e\n\u003cp\u003e8:05\u003c\/p\u003e\n\u003cp\u003eLeadless vs. Leaded Pacemakers – Which One for Which Patient?\u003c\/p\u003e\n\u003cp\u003eAdam Oesterle, MD\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eWhen to Anticoagulate Device-detected Atrial Fibrillation – Latest Evidence\u003c\/p\u003e\n\u003cp\u003eJoshua Moss, MD, MS, FACC\u003c\/p\u003e\n\u003cp\u003e9:25\u003c\/p\u003e\n\u003cp\u003ePACs and Atrial Fibrillation – Association or Causation\u003c\/p\u003e\n\u003cp\u003eEdward Gerstenfeld, MD, MS, FACC\u003c\/p\u003e\n\u003cp\u003e10:05\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e10:20\u003c\/p\u003e\n\u003cp\u003eWhich ICD is Best for my Patient: Transvenous, Subcutaneous (S-ICD), or Extravascular (EV-ICD)?\u003c\/p\u003e\n\u003cp\u003eDaniel Morin, MD, MPH\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003eAtrial Fibrillation and Stroke Prevention – Current Evidence and Glimpse into the Future\u003c\/p\u003e\n\u003cp\u003eCara Pellegrini, MD\u003c\/p\u003e\n\u003cp\u003e11:40\u003c\/p\u003e\n\u003cp\u003eLifestyle and Atrial Fibrillation: Conventional Wisdom versus the Evidence\u003c\/p\u003e\n\u003cp\u003eGregory Marcus, MD, MAS, FACC\u003c\/p\u003e\n\u003cp\u003e12:20 PM\u003c\/p\u003e\n\u003cp\u003eLunch (Optional Product Theater)\u003c\/p\u003e\n\u003cp\u003eSession: Advances and Controversies in Electrophysiology (cont.) Chair: Nora Goldschlager, MD, FACC\u003c\/p\u003e\n\u003cp\u003e1:20 PM\u003c\/p\u003e\n\u003cp\u003eHow to Evaluate Family Members of SCA Victims?\u003c\/p\u003e\n\u003cp\u003eAlbert Liu, MD\u003c\/p\u003e\n\u003cp\u003eSession: Advances in Heart Failure\u003c\/p\u003e\n\u003cp\u003eChair: Jonathan Davis, MD, MPH\u003c\/p\u003e\n\u003cp\u003e1:50\u003c\/p\u003e\n\u003cp\u003eThe Expanding Role of SGLT2 inhibitors and GLP1-Receptor Agonists in Heart Failure and Beyond\u003c\/p\u003e\n\u003cp\u003eCarlos Santos-Gallego, MD\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eA Contemporary Approach to Identifying, Classifying, and Treating Cardiogenic Shock\u003c\/p\u003e\n\u003cp\u003eChristopher Barnett, MD, MHP, FACC\u003c\/p\u003e\n\u003cp\u003e3:10\u003c\/p\u003e\n\u003cp\u003eCoffee Break\u003c\/p\u003e\n\u003cp\u003e3:25\u003c\/p\u003e\n\u003cp\u003eWhat’s Coming Down the Pipe for Heart Failure.\u003c\/p\u003e\n\u003cp\u003eLiviu Klein, MD, MS\u003c\/p\u003e\n\u003cp\u003e4:05\u003c\/p\u003e\n\u003cp\u003eFinerenone vs. Spironolactone: Where Does the Non-steroidal MRA Fit into Contemporary Practice?\u003c\/p\u003e\n\u003cp\u003eShweta Motiwala, MD, MPH, FACC\u003c\/p\u003e\n\u003cp\u003e4:45 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eSunday,\u003c\/p\u003e\n\u003cp\u003eDec 14, 2025\u003c\/p\u003e\n\u003cp\u003e7:30 AM\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e8:00\u003c\/p\u003e\n\u003cp\u003eAnnouncements\u003c\/p\u003e\n\u003cp\u003ePeter Ganz, MD\u003c\/p\u003e\n\u003cp\u003eSession: Advances in Managing Cardiovascular Diseases\u003c\/p\u003e\n\u003cp\u003eChair: Mary Gray, MD\u003c\/p\u003e\n\u003cp\u003e8:05\u003c\/p\u003e\n\u003cp\u003eUpdates in Pericarditis: From Pathophysiology to Practice\u003c\/p\u003e\n\u003cp\u003eAlan Baik, MD, PhD\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eManagement of Cardiovascular Disease for Patients with Kidney Failure Undergoing Maintenance Dialysis\u003c\/p\u003e\n\u003cp\u003eRuth Dubin, MD\u003c\/p\u003e\n\u003cp\u003e9:25\u003c\/p\u003e\n\u003cp\u003eManaging Cardiovascular Disease in Pregnancy\u003c\/p\u003e\n\u003cp\u003eAarthi Sabanayagam, MD, MBBS, FACC\u003c\/p\u003e\n\u003cp\u003e10:05\u003c\/p\u003e\n\u003cp\u003eIron Deficiency: A Low Hanging Mineral in Heart Failure Management\u003c\/p\u003e\n\u003cp\u003ePooja Prasad, MD\u003c\/p\u003e\n\u003cp\u003e10:45\u003c\/p\u003e\n\u003cp\u003eUse of Artificial Intelligence and Machine Learning to Improve Cardiovascular Outcomes\u003c\/p\u003e\n\u003cp\u003eLucas Zier, MD, MS\u003c\/p\u003e\n\u003cp\u003e11:25\u003c\/p\u003e\n\u003cp\u003eInflammation in the Detection and Treatment of Atherosclerotic Disease\u003c\/p\u003e\n\u003cp\u003ePaul M. Ridker, MD, MPH\u003c\/p\u003e\n\u003cp\u003e12:05 PM\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405795807428,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/medicalcoursespro.com\/products\/ucsf-42nd-annual-advances-in-heart-disease-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}